Discipline of Human Physiology and Center for Neuroscience, Flinders University Adelaide, SA, Australia.
Front Neurosci. 2013 Aug 5;7:136. doi: 10.3389/fnins.2013.00136. eCollection 2013.
Recent studies have shown that endogenous serotonin is not required for colonic peristalsis in vitro, nor gastrointestinal (GI) transit in vivo. However, antagonists of 5-Hydroxytryptamine (5-HT) receptors can inhibit peristalsis and GI-transit in mammals, including humans. This raises the question of how these antagonists inhibit GI-motility and transit, if depletion of endogenous 5-HT does not cause any significant inhibitory changes to either GI-motility or transit? We investigated the mechanism by which 5-HT3 and 5-HT4 antagonists inhibit distension-evoked peristaltic contractions in guinea-pig distal colon. In control animals, repetitive peristaltic contractions of the circular muscle were evoked in response to fixed fecal pellet distension. Distension-evoked peristaltic contractions were unaffected in animals with mucosa and submucosal plexus removed, that were also treated with reserpine (to deplete neuronal 5-HT). In control animals, peristaltic contractions were blocked temporarily by ondansetron (1-10 μM) and SDZ-205-557 (1-10 μM) in many animals. Interestingly, after this temporary blockade, and whilst in the continued presence of these antagonists, peristaltic contractions recovered, with characteristics no different from controls. Surprisingly, similar effects were seen in mucosa-free preparations, which had no detectable 5-HT, as detected by mass spectrometry. In summary, distension-evoked peristaltic reflex contractions of the circular muscle layer of the guinea-pig colon can be inhibited temporarily, or permanently, in the same preparation by selective 5-HT3 and 5-HT4 antagonists, depending on the concentration of the antagonists applied. These effects also occur in preparations that lack any detectable 5-HT. We suggest caution should be exercised when interpreting the effects of 5-HT3 and 5-HT4 antagonists; and the role of endogenous 5-HT, in the generation of distension-evoked colonic peristalsis.
最近的研究表明,内源性 5-羟色胺在体外并不需要用于结肠蠕动,也不需要用于体内胃肠道(GI)转运。然而,5-羟色胺(5-HT)受体拮抗剂可以抑制哺乳动物(包括人类)的蠕动和 GI 转运。这就提出了一个问题,即如果内源性 5-HT 的耗竭不会对 GI 动力或转运产生任何显著的抑制变化,那么这些拮抗剂是如何抑制 GI 动力和转运的?我们研究了 5-HT3 和 5-HT4 拮抗剂抑制豚鼠远端结肠扩张诱发蠕动收缩的机制。在对照动物中,固定粪便球囊扩张可诱发环形肌的重复蠕动收缩。在去除黏膜和黏膜下丛并给予利血平(以耗竭神经元 5-HT)的动物中,扩张诱发的蠕动收缩不受影响。在对照动物中,在许多动物中,奥丹赛酮(1-10 μM)和 SDZ-205-557(1-10 μM)可暂时阻断蠕动收缩。有趣的是,在这种暂时阻断之后,并且在这些拮抗剂持续存在的情况下,蠕动收缩恢复,其特征与对照无差异。令人惊讶的是,在没有可检测到的 5-HT 的无黏膜制剂中也观察到类似的效果,如通过质谱法检测到的。总之,在同一制剂中,选择性 5-HT3 和 5-HT4 拮抗剂可暂时或永久抑制豚鼠结肠环形肌层的扩张诱发蠕动反射收缩,这取决于所应用的拮抗剂的浓度。这些作用也发生在缺乏任何可检测到的 5-HT 的制剂中。我们建议在解释 5-HT3 和 5-HT4 拮抗剂的作用时应谨慎;并且在扩张诱发的结肠蠕动中,内源性 5-HT 的作用也应谨慎。